CXCR4 Modified Anti-BCMA CAR T Cells for Multiple Myeloma

Clinical trial NCT04727008 · UNKNOWN

Trial details

NCT number: NCT04727008
Sponsor: Sichuan University
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Multiple Myeloma

Start date: 2022-09-21
Primary completion: 2025-12-31
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.